Opportunistic infection (OI) in recipients of CD34-selected (CD34+) and unselected (UNS) autologous hematopoietic stem cell transplantation (AHSCT) for non-Hodgkin's lymphoma (NHL).

被引:0
|
作者
Raad, JY [1 ]
Hurd, DD [1 ]
Cruz, J [1 ]
Perry, J [1 ]
Radford, J [1 ]
Dodge, W [1 ]
High, KP [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Internal Med, Hematol Oncol Sect, Winston Salem, NC 27109 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4926
引用
收藏
页码:380B / 380B
页数:1
相关论文
共 50 条
  • [31] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis
    MK Gandhi
    HK Jestice
    MA Scott
    DM Bloxham
    G Bass
    JIO Craig
    RE Marcus
    Bone Marrow Transplantation, 1999, 24 : 369 - 375
  • [32] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma:: a case controlled analysis
    Gandhi, MK
    Jestice, HK
    Scott, MA
    Bloxham, DM
    Bass, G
    Craig, JIO
    Marcus, RE
    BONE MARROW TRANSPLANTATION, 1999, 24 (04) : 369 - 375
  • [33] Selection and transplantation of autologous CD34+ peripheral blood stem cells in non-Hodgkin's lymphoma using high-speed fluorescence-activated cell sorting
    Holland, HK
    Fleming, WH
    Waller, EK
    Connaghan, DG
    Geller, RB
    Wingard, JR
    Yeager, AM
    BLOOD, 1996, 88 (10) : 1616 - 1616
  • [34] Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas
    Pichert, G
    Schmitter, D
    Widmer, L
    Jost, LM
    Kurrer, MO
    Maurer, R
    Stahel, RA
    ANNALS OF ONCOLOGY, 1998, 9 (01) : 51 - 54
  • [35] Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL)
    BenYosef, R
    Braverman, I
    Saah, D
    Nagler, R
    Shohat, S
    Or, R
    Nagler, A
    BONE MARROW TRANSPLANTATION, 1996, 18 (05) : 1017 - 1019
  • [36] Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
    Holmberg, LA
    Boeckh, M
    Hooper, H
    Leisenring, W
    Rowley, S
    Heimfeld, S
    Press, O
    Maloney, DG
    McSweeney, P
    Corey, L
    Maziarz, RT
    Appelbaum, FR
    Bensinger, W
    BLOOD, 1999, 94 (12) : 4029 - 4035
  • [37] Higher infused CD34+hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma
    Yoon, Dok Hyun
    Sohn, Byeong Seok
    Jang, Geundoo
    Kim, Eun Kyoung
    Kang, Byung Woog
    Kim, Chul
    Kim, Jeong-Eun
    Kim, Shin
    Lee, Dae Ho
    Lee, Jung-Shin
    Park, Seo-Jin
    Park, Chan-Jeoung
    Huh, Jooryung
    Suh, Cheolwon
    TRANSFUSION, 2009, 49 (09) : 1890 - 1900
  • [38] Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
    Davies, Jeff K.
    Brennan, Lisa L.
    Wingard, John R.
    Cogle, Christopher R.
    Kapoor, Neena
    Shah, Ami J.
    Dey, Bimalangshu R.
    Spitzer, Thomas R.
    de Lima, Marcos
    Cooper, Laurence J.
    Thall, Peter F.
    Champlin, Richard E.
    Nadler, Lee M.
    Guinan, Eva C.
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4098 - 4109
  • [39] Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation
    Allan, DS
    Keeney, M
    Howson-Jan, K
    Popma, J
    Weir, K
    Bhatia, M
    Sutherland, DR
    Chin-Yee, IH
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 967 - 972
  • [40] Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation
    DS Allan
    M Keeney
    K Howson-Jan
    J Popma
    K Weir
    M Bhatia
    DR Sutherland
    IH Chin-Yee
    Bone Marrow Transplantation, 2002, 29 : 967 - 972